Sorry, this is premium content.

Drew Berquist

Is Credit Suisse Next? | Pfizer Acquires Biotech Seagen For $43 Billion | Booze & Banter

Credit Suisse has fallen to a new low and says they have found "material weakness" as experts predict they may be the next bank to fall. Plus, Pfizer is buying Cancer Treatment Biotech Seagen For $43 Billion.